LXRX - Lexicon Pharmaceuticals to offer up to $75M in common stock under agreement
2023-12-29 17:51:44 ET
More on Lexicon Pharmaceuticals
- Lexicon Pharmaceuticals, Inc. (LXRX) Q3 2023 Earnings Call Transcript
- Looking Back In On Lexicon Pharmaceuticals
- Lexicon to present data on cost-effectiveness of Inpefa on Tuesday
- Express Scripts to list Lexicon's Inpefa as preferred Medicare product
- Seeking Alpha’s Quant Rating on Lexicon Pharmaceuticals
For further details see:
Lexicon Pharmaceuticals to offer up to $75M in common stock under agreement